IP Library › Assignment 052666/0575
Patent Assignment
Reel/Frame 052666/0575

Corrective Assignment to Correct the Nature of Conveyance from Assignment to License Agreement Previously Recorded at Reel: 52321 Frame: 294. Assignor(S) Hereby Confirms the License Agreement

Recorded: 2020-05-14 Pages: 76
Assignor
APEIRON BIOLOGICS AG
Executed: 2016-09-27
Assignee
EUSA PHARMA (UK) LIMITED
BREAKSPEAR PARK, BREAKSPEAR WAY, HEMEL HEMPTSTEAD, KP24TZ, UNITED KINGDOM
Covered Property (1)
Method for Treating a GD2 Positive Cancer
Application: 16/375,022 →
Publication: US 2020/0055953
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 6, 2020
From: LOIBNER, HANS; MUTSCHLECHNER, OLIVER; LADENSTEIN, RUTH; KLIER, ISABEL
To: APEIRON BIOLOGICS AG
Reel/Frame 052320/0973 →
Assignment of Assignor's Interest Apr 6, 2020
From: APEIRON BIOLOGICS AG
To: EUSA PHARMA (UK) LIMITED
Reel/Frame 052321/0294 →